Swedencare AB (publ) (SECARE.ST)

SEK 48.8

(-2.4%)

Total Liabilities Summary of Swedencare AB (publ)

  • Swedencare AB (publ)'s latest annual total liabilities in 2023 was 2.31 Billion SEK , down -8.99% from previous year.
  • Swedencare AB (publ)'s latest quarterly total liabilities in 2024 Q3 was 2.25 Billion SEK , down -4.45% from previous quarter.
  • Swedencare AB (publ) reported annual total liabilities of 2.54 Billion SEK in 2022, up 141.98% from previous year.
  • Swedencare AB (publ) reported annual total liabilities of 1.05 Billion SEK in 2021, up 383.29% from previous year.
  • Swedencare AB (publ) reported quarterly total liabilities of 2.25 Billion SEK for 2024 Q3, down -4.45% from previous quarter.
  • Swedencare AB (publ) reported quarterly total liabilities of 2.35 Billion SEK for 2024 Q2, down -0.78% from previous quarter.

Annual Total Liabilities Chart of Swedencare AB (publ) (2023 - 2013)

Historical Annual Total Liabilities of Swedencare AB (publ) (2023 - 2013)

Year Total Liabilities Total Liabilities Growth
2023 2.31 Billion SEK -8.99%
2022 2.54 Billion SEK 141.98%
2021 1.05 Billion SEK 383.29%
2020 217.53 Million SEK 1100.57%
2019 18.11 Million SEK -7.54%
2018 19.59 Million SEK -23.58%
2017 25.64 Million SEK -28.9%
2016 36.06 Million SEK 85.81%
2015 19.41 Million SEK 213.5%
2014 6.19 Million SEK 184.53%
2013 2.17 Million SEK 0.0%

Peer Total Liabilities Comparison of Swedencare AB (publ)

Name Total Liabilities Total Liabilities Difference
AcuCort AB 10.97 Million SEK -20996.128%
AlzeCure Pharma AB (publ) 8.22 Million SEK -28042.701%
BioGaia AB (publ) 302.84 Million SEK -664.517%
Enzymatica AB (publ) 49.3 Million SEK -4596.158%
Enorama Pharma AB (publ) 14.84 Million SEK -15494.396%
Gabather AB (publ) 6.87 Million SEK -33562.402%
Klaria Pharma Holding AB (publ.) 31.98 Million SEK -7138.479%
Moberg Pharma AB (publ) 24 Million SEK -9544.27%
Nanexa AB (publ) 36.42 Million SEK -6256.0%
Newbury Pharmaceuticals AB (publ) 38.95 Million SEK -5843.677%
ODI Pharma AB 10.05 Million SEK -22920.233%
Orexo AB (publ) 727.7 Million SEK -218.167%
Probi AB (publ) 181.31 Million SEK -1176.928%
Swedish Orphan Biovitrum AB (publ) 40.16 Billion SEK 94.235%
Toleranzia AB 6.9 Million SEK -33411.362%
Vivesto AB 30.45 Million SEK -7503.113%